|
| Status |
Public on Nov 02, 2020 |
| Title |
NimbleGen 007-01-30_HG18_5189_refseq |
| Technology type |
in situ oligonucleotide |
| Distribution |
custom-commercial |
| Organism |
Homo sapiens |
| Manufacturer |
NimbleGen |
| Manufacture protocol |
OID5189. Chr11 regions pulled from hg18_tiling database (14161 probes). Used refseq design 2006-04-28_HG18_Refseq_Promoter design, adjusted length of each region covered by %5 to make room for chr11 probes (371615 probes)
|
| |
|
| Description |
HG18
This microarray was a custom design based on the HG18 RefSeq promoter design, plus 2Mb of sequences surrounding WT1 gene and some other CpG rich sequences not covered in the standard Nimblegen chip.
|
| |
|
| Submission date |
Jun 23, 2020 |
| Last update date |
Nov 04, 2020 |
| Contact name |
Keith William Brown |
| E-mail(s) |
[email protected]
|
| Phone |
+441173312071
|
| Organization name |
University of Bristol
|
| Department |
School of Cellular and Molecular Medicine
|
| Lab |
Cancer Epigenetics Laboratory
|
| Street address |
Biomedical Sciences Building, University Walk
|
| City |
Bristol |
| State/province |
- |
| ZIP/Postal code |
BS8 1TD |
| Country |
United Kingdom |
| |
|
| Samples (3) |
GSM4633517, GSM4633518, GSM4633519 |
| Series (1) |
| GSE153047 |
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor |
|
